Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08XMM
|
|||
| Former ID |
DNCL003043
|
|||
| Drug Name |
NicVAX
|
|||
| Indication | Nicotine dependence [ICD-11: 6C4A.2; ICD-10: F17.2; ICD-9: 305.1] | Phase 3 | [1] | |
| Company |
GlaxoSmithKline; Nabi Biopharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00836199) NicVAX/Placebo as an Aid for Smoking Cessation. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.